The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis

Journal of Neuroinflammation

Olaf Stüve⁶  Scott S Zamvil²  Martin S Weber¹  Bernhard Hemmer⁶  Hans-Peter Hartung⁵  Cyd Castro-Rojas⁴  Brenda C Timmons³  Li-Hong Ben⁴  Benjamine Arellano⁴  Emily Herndon⁷  Rehana Hussain⁴  Bernd C Kieseier⁵  Petra D Cravens⁴ 

[1] Department of Neuropathology, University Medical Center, Georg August University, Göttingen, 37975, Germany;Program in Immunology, University of California, San Francisco, CA, 94143, USA;Hamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390, USA;Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390-9036, USA;Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, 40225, Germany;Department of Neurology, Klinikum rechts der Isar, Technische Universität München, München, 81675, Germany;Department of Pathology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 75390, USA

关键词: T helper cells 17;    Rodent;    Multiple sclerosis;    Mouse;    MS;    MHC;    Major histocompatibility complex;    Lymphocytes;    Human;    Experimental autoimmune encephalomyelitis;    EAE;    Development;    Autoimmunity;    Antigen presentation;    Age;   

Others  :  1159962
DOI  :  10.1186/1742-2094-10-67

 received in 2013-02-20, accepted in 2013-05-06,  发布年份 2013

【 摘 要 】

Multiple sclerosis (MS) is thought to be a CD4⁺ T cell mediated autoimmune demyelinating disease of the central nervous system (CNS) that is rarely diagnosed during infancy. Cellular and molecular mechanisms that confer disease resistance in this age group are unknown. We tested the hypothesis that a differential composition of immune cells within the CNS modulates age-associated susceptibility to CNS autoimmune disease. C57BL/6 mice younger than eight weeks were resistant to experimental autoimmune encephalomyelitis (EAE) following active immunization with myelin oligodendrocyte glycoprotein (MOG) peptide (p) 35–55. Neonates also developed milder EAE after transfer of adult encephalitogenic T cells primed by adult or neonate antigen presenting cells (APC). There was a significant increase in CD45⁺ hematopoietic immune cells and CD45⁺ high side scatter granulocytes in the CNS of adults, but not in neonates. Within the CD45⁺ immune cell compartment of adults, the accumulation of CD4⁺ T cells, Gr-1⁺ and Gr-1^- monocytes and CD11c⁺ dendritic cells (DC) was identified. A significantly greater percentage of CD19⁺ B cells in the adult CNS expressed MHC II than neonate CNS B cells. Only in the adult CNS could IFNγ transcripts be detected 10 days post immunization for EAE. IFNγ is highly expressed by adult donor CD4⁺ T cells that are adoptively transferred but not by transferred neonate donor cells. In contrast, IL-17 transcripts could not be detected in adult or neonate CNS in this EAE model, and neither adult nor neonate donor CD4⁺ T cells expressed IL-17 at the time of adoptive transfer.

【 授权许可】

   
2013 Cravens et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Frohman EM, Racke MK, Raine CS: Multiple sclerosis–the plaque and its pathogenesis. N Engl J Med 2006, 354:942-955.
• [2]Poser S, Raun NE, Poser W: Age at onset, initial symptomatology and the course of multiple sclerosis. Acta Neurol Scand 1982, 66:355-362.
• [3]Kurtzke JF, Page WF, Murphy FM, Norman JE Jr: Epidemiology of multiple sclerosis in US veterans. 4. Age at onset. Neuroepidemiology 1992, 11:226-235.
• [4]Bejar JM, Ziegler DK: Onset of multiple sclerosis in a 24-month-old child. Arch Neurol 1984, 41:881-882.
• [5]Tanoue K, Yamashita S, Masuko K, Osaka J, Iai M, Yamada M: Two cases of acute disseminated encephalomyelitis which occurred before the age of 24 months. No To Hattatsu 2006, 38:363-367.
• [6]Zamvil SS, Steinman L: The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 1990, 8:579-621.
• [7]Stuve O, Youssef S, Slavin AJ, King CL, Patarroyo JC, Hirschberg DL, Brickey WJ, Soos JM, Piskurich JF, Chapman HA, Zamvil SS: The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J Immunol 2002, 169:6720-6732.
• [8]Slavin AJ, Soos JM, Stuve O, Patarroyo JC, Weiner HL, Fontana A, Bikoff EK, Zamvil SS: Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest 2001, 108:1133-1139.
• [9]Wekerle H, Linington C, Lassmann H, Meyermann R: Cellular immune reactivity within the CNS. Trends Neurosci 1986, 9:271-277.
• [10]Hickey WF, Hsu BL, Kimura H: T-lymphocyte entry into the central nervous system. J Neuro Sci Res 1991, 28:254-260.
• [11]Greter M, Heppner FL, Lemos MP: Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med 2005, 11:328-334.
• [12]Traugott U, Scheinberg LC, Raine CS: On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation. J Neuro Immunol 1985, 8:1-14.
• [13]Sakai K, Tabira T, Endoh M, Steinman L: Ia expression in chronic relapsing experimental allergic encephalomyelitis induced by long-term cultured T cell lines in mice. Lab Invest 1986, 54:345-352.
• [14]Steiniger B, Van der Meide PH: Rat ependyma and microglia cells express class II MHC antigens after intravenous infusion of recombinant gamma interferon. J Neuro Immunol 1988, 19:111-118.
• [15]Gresser O, Hein A, Riese S, Regnier-Vigouroux A: Tumor necrosis factor alpha and interleukin-1 alpha inhibit through different pathways interferon-gamma-induced antigen presentation, processing and MHC class II surface expression on astrocytes, but not on microglia. Cell Tissue Res 2000, 300:373-382.
• [16]Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
• [17]Hemmer B, Archelos JJ, Hartung HP: New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neuro Sci 2002, 3:291-301.
• [18]Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM: Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993, 72:551-560.
• [19]Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B: TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
• [20]McCandless EE, Wang Q, Woerner BM, Harper JM, Klein RS: CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J Immunol 2006, 177:8053-8064.
• [21]Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, Sher A, Littman DR: Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000, 20:4106-4114.
• [22]Cravens PD, Hussain RZ, Zacharias TE, Ben LH, Hernden E, Vinnakota R, Lambracht-Washington D, Nessler S, Zamvil SS, Eagar TN, Stuve O: Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation 2011, 8:73. BioMed Central Full Text
• [23]Smith ME, Eller NL, McFarland HF, Racke MK, Raine CS: Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis. Am J Pathol 1999, 155:1147-1161.
• [24]Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, Killian J, Zhang JZ: Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol 2004, 172:5120-5127.
• [25]Genain CP, Cannella B, Hauser SL, Raine CS: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 1999, 5:170-175.
• [26]Crayton H, Heyman RA, Rossman HS: A multimodal approach to managing the symptoms of multiple sclerosis. Neurology 2004, 63:S12-S18.
• [27]Kabat EA, Moore DH, Landow H: An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J Clin Invest 1942, 21:571-577.
• [28]Siden A: Abnormal CSF, immunoglobulin components detected by isoelectric focusing. J Neurol 1980, 224:133-144.
• [29]Link H, Huang YM: Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness. J Neuroimmunol 2006, 180:17-28.
• [30]Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983, 13:227-231.
• [31]Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS: Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005, 58:840-846.
• [32]O'Connor KC, Chitnis T, Griffin DE, Piyasirisilp S, Bar-Or A, Khoury S, Wucherpfennig KW, Hafler DA: Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003, 136:140-148.
• [33]O'Connor KC, Appel H, Bregoli L, Call ME, Catz I, Chan JA, Moore NH, Warren KG, Wong SJ, Hafler DA, Wucherpfennig KW: Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein. J Immunol 2005, 175:1974-1982.
• [34]Kanter JL, Narayana S, Ho PP: Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 2006, 12:138-143.
• [35]Rodriguez-Pinto D: B cells as antigen presenting cells. Cell Immunol 2005, 238:67-75.
• [36]Massa PT, ter MV, Fontana A: Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 1987, 84:4219-4223.
• [37]Slavin AJ, Soos JM, Stuve O: Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J Clin Invest 2001, 108:1133-1139.
• [38]Boss JM: Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997, 9:107-113.
• [39]Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL: Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Mol Immunol 2006, 43:519-528.